[1]
Gottlieb, A.B., Deodhar, A., Mcinnes, I.B., Baraliakos, X., Reich, K., Schreiber, S., Bao, W., Marfo, K. , Richards, H.B., Pricop, L., Shete, A., Trivedi, V., Keefe, D., Papavassilis, C.C., Jagiello, P., Papanastasiou, P. , Mease, P.J. and Lebwohl, M. 2022. Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data. Acta Dermato-Venereologica. 102, (Apr. 2022), adv00698. DOI:https://doi.org/10.2340/actadv.v102.563.